• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

再生障碍性贫血患者铁代谢异常及铁过载的研究

[Study on abnormal iron metabolism and iron overload in patients with aplastic anemia].

作者信息

Jin Peng, Shi Jun, Li Xing-xin, Shao Ying-qi, Nie Neng, Ge Mei-li, Zhang Jing, Huang Zhen-dong, Huang Jin-bo, Zheng Yi-zhou

机构信息

Institute of Hematology and Blood Disease Hospital, CAMS & PUMC, Tianjin 300020, China.

出版信息

Zhonghua Xue Ye Xue Za Zhi. 2013 Oct;34(10):877-82. doi: 10.3760/cma.j.issn.0253-2727.2013.10.011.

DOI:10.3760/cma.j.issn.0253-2727.2013.10.011
PMID:24171963
Abstract

OBJECTIVE

To investigate the abnormalities of iron metabolism, the prevalence and risk factors of iron overload and clinical characteristics of patients with aplastic anemia (AA).

METHODS

A cross-sectional study was conducted on 520 newly diagnosed AA patients.

RESULTS

Iron overload was observed in 66(13%) of 520 AA patients,in which a higher prevalence of iron overload was seen not only in patients with infections(19/86, 22%)than those without infections (47/434, 11%, P<0.01), but also in patients with hepatitis associated AA(HAAA) (6/22, 19%) than the idiopathic cases (60/488, 12%, P>0.05). Excluded the patients with infections and/or HAAA, 43 of 405(11%)cases had iron overload, including 14 of 248(6%) cases without history of blood transfusion and 29 of 157 patients (18%, P<0.01) with transfusion. In univariate analysis, higher levels of serum ferritin (SF), serum iron (SI) and transferrin saturation (TS) were mainly observed in adult male patients with severe AA (SAA) and significantly upward with increasing blood transfusion (P<0.01). No differences of soluble transferrin receptor (sTfR) were observed between adults and children, males and females, hepatitis and idiopathic AA. However, patients with infections had significantly lower level of sTfR (0.50 mg/L) than cases without infections (0.79 mg/L, P<0.01). The level of sTfR in SAA patients (0.70 mg/L) was only half of that in non-SAA (NSAA) (1.36 mg/L, P<0.01). Patients with increasing blood transfusion had significantly downward levels of sTfR (P<0.01). In multivariate analysis, more than 8 U blood transfusion (OR=10.52, P<0.01), adults (OR=3.48, P<0.01), males (OR=3.32, P<0.01) and infections (OR=2.09, P<0.01) were independent risk factors.

CONCLUSION

AA patients had higher iron burden and were high-risk populations occurring iron overload. The iron overload occurred in 18% of patients with blood transfusion and in 6% of patients without transfusion.

摘要

目的

探讨再生障碍性贫血(AA)患者铁代谢异常、铁过载的发生率及危险因素和临床特征。

方法

对520例新诊断的AA患者进行横断面研究。

结果

520例AA患者中66例(13%)存在铁过载,其中感染患者铁过载发生率(19/86,22%)高于未感染患者(47/434,11%,P<0.01),肝炎相关性AA(HAAA)患者铁过载发生率(6/22,19%)高于特发性病例(60/488,12%,P>0.05)。排除感染和/或HAAA患者后,405例中有43例(11%)存在铁过载,其中248例未输血患者中有14例(6%),157例输血患者中有29例(18%,P<0.01)。单因素分析显示,血清铁蛋白(SF)、血清铁(SI)和转铁蛋白饱和度(TS)水平较高主要见于成年男性重型AA(SAA)患者,且随输血次数增加显著升高(P<0.01)。可溶性转铁蛋白受体(sTfR)在成人与儿童、男性与女性、肝炎相关性AA与特发性AA之间未见差异。然而,感染患者的sTfR水平(0.50 mg/L)显著低于未感染患者(0.79 mg/L,P<0.01)。SAA患者的sTfR水平(0.70 mg/L)仅为非SAA患者(NSAA)(1.36 mg/L,P<0.01)的一半。输血次数增加的患者sTfR水平显著降低(P<0.01)。多因素分析显示,输血超过8 U(OR=10.52,P<0.01)、成人(OR=3.48,P<0.01)、男性(OR=3.32,P<0.01)和感染(OR=2.09,P<0.01)是独立危险因素。

结论

AA患者铁负荷较高,是发生铁过载的高危人群。铁过载在18%的输血患者和6%的未输血患者中出现。

相似文献

1
[Study on abnormal iron metabolism and iron overload in patients with aplastic anemia].再生障碍性贫血患者铁代谢异常及铁过载的研究
Zhonghua Xue Ye Xue Za Zhi. 2013 Oct;34(10):877-82. doi: 10.3760/cma.j.issn.0253-2727.2013.10.011.
2
Deferasirox improves hematologic and hepatic function with effective reduction of serum ferritin and liver iron concentration in transfusional iron overload patients with myelodysplastic syndrome or aplastic anemia.地拉罗司可改善血液学和肝功能,有效降低骨髓增生异常综合征或再生障碍性贫血伴输血铁过载患者的血清铁蛋白和肝脏铁浓度。
Transfusion. 2014 Jun;54(6):1542-51. doi: 10.1111/trf.12507. Epub 2013 Dec 3.
3
[Effects of pre-immunosupressive therapy iron overload on hematologic response of severe aplastic anemia].[免疫抑制治疗前铁过载对重型再生障碍性贫血血液学反应的影响]
Zhonghua Xue Ye Xue Za Zhi. 2016 Apr;37(4):324-8. doi: 10.3760/cma.j.issn.0253-2727.2016.04.015.
4
[Detection of Hepcidin in transfusion dependent myelodysplastic syndrome patients and its clinical significance].[输血依赖型骨髓增生异常综合征患者中铁调素的检测及其临床意义]
Zhonghua Xue Ye Xue Za Zhi. 2011 Nov;32(11):758-61.
5
Evolution of iron burden in acquired aplastic anemia: a cohort study of more than 3-year follow-up.获得性再生障碍性贫血中铁负荷的演变:一项超过3年随访的队列研究
Int J Hematol. 2015 Jan;101(1):13-22. doi: 10.1007/s12185-014-1708-6. Epub 2014 Nov 28.
6
[Clinical significance of serum transferrin receptor in differential diagnosis of anemia].血清转铁蛋白受体在贫血鉴别诊断中的临床意义
Zhonghua Nei Ke Za Zhi. 2004 Jun;43(6):423-5.
7
[Clinical study of iron metabolism indicators in ineffective hematopoiesis of myelodysplastic syndrome].骨髓增生异常综合征无效造血中铁代谢指标的临床研究
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Aug;21(4):948-52. doi: 10.7534/j.issn.1009-2137.2013.04.026.
8
Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality.一项针对日本输血依赖型骨髓增生异常综合征和再生障碍性贫血患者的全国性回顾性调查凸显了铁过载对发病率/死亡率的负面影响。
Eur J Haematol. 2007 Jun;78(6):487-94. doi: 10.1111/j.1600-0609.2007.00842.x. Epub 2007 Mar 28.
9
Transforming growth factor 15 increased in severe aplastic anemia patients.转化生长因子15在重型再生障碍性贫血患者中升高。
Hematology. 2017 Oct;22(9):548-553. doi: 10.1080/10245332.2017.1311462. Epub 2017 Apr 6.
10
Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.黎巴嫩镰状细胞病患者存在输血负担、肝铁和血清铁过载,但 MRI T2* 未见心脏含铁血黄素沉积。
Eur J Haematol. 2009 Dec 1;83(6):565-71. doi: 10.1111/j.1600-0609.2009.01345.x. Epub 2009 Sep 8.

引用本文的文献

1
From Biology to Clinical Practice: Iron Chelation Therapy With Deferasirox.从生物学到临床实践:去铁胺螯合疗法
Front Oncol. 2021 Oct 6;11:752192. doi: 10.3389/fonc.2021.752192. eCollection 2021.
2
[Effects of pre-immunosupressive therapy iron overload on hematologic response of severe aplastic anemia].[免疫抑制治疗前铁过载对重型再生障碍性贫血血液学反应的影响]
Zhonghua Xue Ye Xue Za Zhi. 2016 Apr;37(4):324-8. doi: 10.3760/cma.j.issn.0253-2727.2016.04.015.
3
[Efficacy and safety of deferasirox in aplastic anemia patients with iron overload: a single arm, multi-center,prospective study in China].
地拉罗司治疗铁过载再生障碍性贫血患者的疗效与安全性:一项在中国开展的单臂、多中心、前瞻性研究
Zhonghua Xue Ye Xue Za Zhi. 2016 Jan;37(1):1-6. doi: 10.3760/cma.j.issn.0253-2727.2016.01.001.